GSK Investigational Site

Cherkasy 18009

0 studies enrolling now · 3 studies all time

What they study most

Anaemia, Arthritis, Rheumatoid, Deep Vein Thrombosis, Fibrillation, Atrial, Pulmonary Embolism, Venous Thromboembolism

Studies at this site

• Anemia Studies in Chronic Kidney Disease: Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor Daprodustat-Non-Dialysis (ASCEND-ND) — Completed
• Long-term Safety and Efficacy of GSK3196165 (Otilimab) in the Treatment of Rheumatoid Arthritis (RA) — Stopped early
• Odiparcil For The Prevention Of Venous Thromboembolism — Completed